IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Similar documents
Katee Kindler, PharmD, BCACP

Reduction of High Risk Medications Using A Quality Initiative Perspective

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay

Polypharmacy in the Elderly

Patient Safety in an Aging World. Patient Safety in Aging Society Tokyo, 13 April 2018 Albert W. Wu, MD, MPH Professor, Johns Hopkins University

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Deprescribing Unnecessary Medications: A Four-Part Process

Presented by: Ontario s Geriatric Steering Committee

Medication Management When Caring for Seniors at Home

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology

Arkansas Prescription Monitoring Program

Disclosures. Learning Objectives 4/26/2017

Strategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS

If a bad thing is happening to a patient, a drug did it until proven otherwise

About ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form

Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate

Supplementary Online Content

Polypharmacy & De-prescribing In Older Adults

Meds and Falls: Keep in Step with your Meds

PDMP Tools to Identify Red Flag Situations

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Adverse Drug Events, which includes Opioids. Stevi Sy PharmD, RPh Regional Medication Safety Lead Mountain-Pacific Quality Health May 16, 2018

4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND

Stronger together - optimizing pharmacotherapy on geriatric wards?

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Less is More: Introduction to Deprescribing

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Safe Prescribing of Drugs with Potential for Misuse/Diversion

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York

Budnitz DS et al. NEJM Background

Polypharmacy: Making it all Work Kathy Wilson, RPh, RWSIR Director of Pharmacy

Overview of Health IT in Massachusetts: Data to Inform and Improve Performance

Med Wreck to Med Rec How medication reconciliation can (should) change your practice!

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

TITLE AUTHORS. Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

Mucky Meds: A (practical) approach the nightmare med list. Michelle Gibson, MD, CCFP (COE), FCFP and Erin Beattie, MD, CCFP

To Prescribe or Not To Prescribe

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Zolpidem Is Independently Associated With Increased Risk of Inpatient Falls

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

DEPRESCRIBING IN THE ELDERLY

Pharmaceutical Society of Singapore Pharmacy Week Polypharmacy in Singapore: The Role of Deprescribing

Outline. Disclosure. Sleep and the Elderly 1,2. Background

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs --- United States,

Ontario s Narcotics Strategy

Getting Hypertension Under Control

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Sleep and Falls. Katie L. Stone, Ph.D. October 4-6, 2015

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Objectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016

Objective. A Multi Incident Analysis on Potentially Inappropriate Medication Use in Older Adults. Outline

Therapeutics Initiative A SHORT HISTORY

*Drug-drug Interactions and Polypharmacy in HIV and Aging

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping

Michigan Automated Prescription System

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Managing Opioid Overutilization Challenges

Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Section I. Short-acting opioid Prior Authorization Criteria

Medication Management

Opioid Overdose Education and Naloxone Distribution

4/3/2018. The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers. Learning Objectives

Disclosure. Screening for adverse drug events: a tool to improve safe medication use

Prescription Switching and Reduced LDL-C Goal Attainment

Clinical contracts. Dr. Johan Wouterloot Prescribers Course April 28, 2017

Objectives. Quality Improvement: Learning Collaboratives & Pharmacist involvement

SURVEY ABOUT YOUR PRESCRIPTION CHOICES

Welcome - we will begin the webinar shortly Please read the participation tips below:

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist

Antipsychotic Medications

Objectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

Opioid Report Card. opioid oversight from MN Dept of Health

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

Using CURES to combat prescription drug abuse/misuse

Can klonopin help withdrawal opiates

Medication safety in vulnerable patient groups - Elderly patients -

Medication Therapy Management: Improving Health and Saving Money

Drug Safety in Ambulatory Care

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

MEDICINES ADHERENCE The Role of the Pharmacist

Pharmaceutical Misuse and its Challenges: Opioid Use in Ontario. Ontario Harm Reduction Conference Tara Gomes Tuesday January 31, 2012

If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help

Transcription:

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Improving Medication Safety Among Elderly Patients in an Ambulatory Setting Background & Objectives Methods Timeline Results Summary

Background & Statistics Older patients have a higher prevalence of comorbidities & other physiological changes that increase risk of harm Medications don t have the same risk-benefit profile for the elderly In 2012, there were 43.1 million Americans aged 65 & older (U.S. Census Bureau, 2012) By 2030, estimated 20% of the American population will be 65 & older Thought to increase to 83.7 million by 2050 An estimated 99,000 elderly patients are admitted to the hospital annually due to medication-related events

Background: What is the Beers List? Ages 65 and older Medications that can cause adverse reactions in the elderly Used by healthcare providers to help choose the right medications for patients health conditions Updated periodically by the American Geriatric Society Last updated in 2015

Background: Why is the Beers List important? Helps eliminate: Polypharmacy Complex regimens Preventable adverse events or side effects

Inappropriate Medications in the Elderly Cardiovascular meds Benzodiazepines Antidepressants Anticholinergics Others Possible adverse events: Delirium/confusion Cardiovascular issues Increased risk of falls

Literature Review: Prior Attempts Patient education (Tannenbaum et al, 2014) EMPOWER study educated patients so they could make an informed decision Outcome: Discontinuation rate of 27% compared with 5% in control group (6 months later) 11% of patients achieved dose reduction Prescription flags (Raebel et al, 2007) Alerts for pharmacists at the point of script verification Risky medications for the patient s age

Objective To improve medication safety among elderly ambulatory patients via student pharmacist medication review. Options: Discontinue medication Decrease dose to lessen the chance or effect of an adverse event Switch medication to safer alternative

Improving Medication Safety Among Elderly Patients in an Ambulatory Setting Background & Objectives Methods Timeline Results Summary

Methods Received report (Nov 2016 by PPRNet) of patients age 65 and older who had a Beers List medication on their med list Site: Northeast Iowa Family Practice Center (Waterloo, Iowa)

Methods Inclusion criteria: Age 65 and older Beers List medication on med list Active patient at site Exclusion criteria: No-contact list Hospice Deceased

Methods Student Pharmacist Patient Physician

Methods 1) Lit review and project design Developed scripts for phone interactions with patients Developed scripts for email interactions with physicians Created shared database for patient data collection 2) Access to and training on EMR system 3) Chart review via EMR To determine which medication was flagged by the report

Methods 4) Called patient (if needed) To see if still taking the medication & how often 5) Determined final drug therapy change Discontinuation, taper off, or switch to a safer alternative 6) Contacted doctor via EMR To ask permission for drug therapy change

Methods 7) If approved, contacted patient To educate, inform of drug therapy change, and assess willingness to participate in regimen change 8) Contacted physician or Dr. Hoehns (if needed) To have Rx sent to pharmacy 9) Contacted patient for follow-up at least 2 weeks laer To see if new Rx was picked up, and assess how drug regimen change is working

Improving Medication Safety Among Elderly Patients in an Ambulatory Setting Background & Objectives Methods Timeline Results Summary

Timeline Fall 2016 Lit review & project design Developed script for physician email Developed script for patient phone calls Assigned patients to each student pharmacist & created shared Excel document for data collection Training on EMR system (Dec. 2016)

Timeline Spring & Summer 2017 Approval of QI project by Northeast Iowa Family Practice Center Ethics Board (Jan. 2017) Data collection & patient contact (Mar-July 2017) Review of data collection & formulation of results (Aug. 2017)

Improving Medication Safety Among Elderly Patients in an Ambulatory Setting Background & Objectives Methods Timeline Results Summary

Results Patients / Exclusion Criteria N Original Patients 125 Not Reviewed by Student 18 Beers List medication no longer on med list 5 No Contact List 1 Not an Active Patient at Site 1 Deceased 3 TOTAL PATIENTS 96

Medication Class N (%) Results Anticholinergic/autonomic 20 (20.8) Antihistamine 16 (16.7) Anxiolytic/Sedative/Hypnotic 16 (16.7) Analgesic 14 (14.6) Gastrointestinal 7 (7.3) Hormones/Substitutes 6 (6.3) Psychotherapeutic Agents 13 (13.5) Cardiovascular 2 (2.1) CNS 2 (2.1) Frequency of Use PRN 43 (44.8) Scheduled Regularly 53 (55.2) Months of Medication Use, mean (SD) 39.6 (49.9)

Example Interventions Patient on Tylenol PM Discontinue & swtich to APAP + Trazodone Patient on Zolpidem 10mg + Trazodone 200mg Dose changes to Zolpidem 5mg + Trazodone 100mg Patient on Glyburide Discontinue & switch to Glipizide Patient on Lorazepam 0.5mg QHS PRN Discontinue

Results Responses from Student Intervention Number (%) Patient no longer taking med of concern 28 (29.2) Unable to reach patient via telephone 19 (19.8) Patient refused student med recommendation 12 (12.5) Physician did not approve med recommendation 11 (11.5) Physician did not reply to EMR message from student 9 (9.4) Medication change made (Physician approved, patient approved, and changes made) 6 (6.3) Best option to stay on current medication 5 (5.2) Other 6 (6.3)

Improving Medication Safety Among Elderly Patients in an Ambulatory Setting Background & Objectives Methods Timeline Results Summary

Summary Strengths There is value in discontinuing medications from a medication list Improved patient & provider understanding of current medications and their risks Increased provider awareness of inappropriate medications among the elderly population

Summary Limitations Inability to contact patients Change of EMR mid-study Patients inactive/unwilling to participate in intervention

Summary 35.4% of patients had a positive outcome 28/96 patients had a medication taken of their record that they were not taking 6/96 patients had an inappropriate medication discontinued/changed Minimizing the use of potentially inappropriate medications in the elderly will likely require multifaceted approaches.

References Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002 2012. Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, Magid DJ. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007 Jul;55(7):977-85. Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890 8. doi: 10.1001/jamainternmed.2014.949 An Aging Nation: The Older Population In the United States. US Census Bureau. 2012. https://www.census.gov/prod/2014pubs/p25-1140.pdf

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Review Link http://bit.ly/discoveryhoehns